Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians (Q5122844)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians |
scientific article; zbMATH DE number 7251468
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Challenges in implementing adaptive designs: comments on the viewpoints expressed by regulatory statisticians |
scientific article; zbMATH DE number 7251468 |
Statements
Challenges in Implementing Adaptive Designs: Comments on the Viewpoints Expressed by Regulatory Statisticians (English)
0 references
24 September 2020
0 references
adaptive designs
0 references
adaptive information design
0 references
adaptive study designs
0 references
clinical trial simulation
0 references
biostatistics
0 references
dropping a treatment arm
0 references
experimental design
0 references
FDA critical path
0 references
guidance development
0 references
missing data
0 references
multiple endpoints
0 references
non-inferiority
0 references
non-inferiority trials
0 references
phase III clinical trials
0 references
quantitative risk/safety assessment
0 references
regulatory evaluation
0 references
superiority
0 references
0.942335844039917
0 references
0.937932789325714
0 references
0.9178054928779602
0 references
0.9057104587554932
0 references
